
CME · Nasdaq
CME Group operates global trading markets, including futures and options venues, and earns revenue from facilitating and clearing transactions. Its products span interest rates, equity indexes, foreign exchange, commodities, and increasingly cryptocurrency, serving institutional investors, corporations, asset managers, hedge funds, and other market participants. The supplied evidence does not provide a segment revenue split, so the relative contribution of each product category cannot be quantified here. CME generated $6.5 billion of revenue and $4.1 billion of net income in fiscal 2025, up from $6.1 billion and $3.5 billion, respectively, in fiscal 2024.
CME Group rose $2.63, or 1.01%, from $260.00 to $262.63 over the stated period. The stock first advanced sharply, reaching $267.79 by July 31, before reversing: it slipped to $266.17 on August 3 and fell another $3.54 on August 4, giving back most of the earlier gain. No CME-specific announcement, earnings release, contract win, or guidance change appears in the supplied evidence, so the move is best viewed against a broader macro backdrop. Market commentary focused on potential oil-price pressure from Iran escalation and tariffs, alongside uncertainty over whether Federal Reserve Chair Kevin Warsh would remain hawkish. Those themes may have influenced expectations for volatility, rates, and trading activity.